MDR1 and AKT expression decreased with increasing anlotinib concentration.<h4>Conclusion</h4>Anlotinib suppressed the proliferation of 5-FU-resistant colon cancer cells by preventing entry into S phase, thus sensitizing cells to 5-FU. This evidence concerns the gene AKT1 and malignant colon neoplasm.